Vladimír Wsól (Vladimir Wsol)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 7

Top Venues

Archives of toxicology

Cancers

BioMed research international

Pharmaceutics

Charles University, Faculty of Pharmacy in Hradec Kralove

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charles University, Faculty of Pharmacy in Hradec Kralove Sep 01 1990

Czechia

Professor :: Department of Biochemical Sciences

Publications

Lucie Čermáková, Jakub Hofman, Lenka Laštovičková, Lucie Havlíčková, Ivona Špringrová, Eva Novotná, Vladimír Wsól
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux. Pharmaceutics 14 (10) (2022)
Anselm Morell, Youssif Budagaga, Dimitrios Vagiannis, Yu Zhang, Lenka Laštovičková, Eva Novotná, Andrew Haddad, Melodie Haddad, Ramon Portillo, Jakub Hofman, Vladimír Wsól
Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters. Archives of toxicology 96 (12) (2022)
Tássia S Tavares, Jakub Hofman, Alžběta Lekešová, Jana Želazková, Vladimír Wsól
Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3. Cancers 12 (11) (2020)
Anselm Morell, Lucie Čermáková, Eva Novotná, Lenka Laštovičková, Melodie Haddad, Andrew Haddad, Ramon Portillo, Vladimír Wsól
Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3. Cancers 12 (12) (2020)
Eva Novotná, Anselm Morell, Neslihan Büküm, Jakub Hofman, Petra Danielisová, Vladimír Wsól
Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens? Archives of toxicology 94 (9) (2020)
Anselm Morell, Eva Novotná, Jaroslav Milan, Petra Danielisová, Neslihan Büküm, Vladimír Wsól
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism. Archives of toxicology 95 (1) (2020)
Eva Novotná, Neslihan Büküm, Jakub Hofman, Michaela Flaxová, Etela Kouklíková, Dagmar Louvarová, Vladimír Wsól
Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile. Archives of toxicology 92 (9) (2018)
Patrik Aronsson, Renata Vesela, Martin Johnsson, Yasin I Tayem, Vladimír Wsól, Michael Winder, Gunnar Tobin
Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat. BioMed research international 2014 (2014)

Vladimír Wsól.css-eqlu8i{font-size:small;padding-left:4px;} (Vladimir Wsol)

Publication Activity (10 Years)

Top Topics

Top Venues

Vladimír Wsól (Vladimir Wsol)